Supernus Pharmaceuticals | SUPN - Pre Tax Profit

Stock Price
51.65
Daily Change
2.28 4.62%
Monthly
0.80%
Yearly
34.51%
Q1 Forecast
46.68

Supernus Pharmaceuticals reported $-57.95M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Abbott USD 2.36B 178M Dec/2025
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Aurora Cannabis CAD 46.98M 66.36M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Canopy Growth CAD -1.42M 39.82M Sep/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Eisai JPY 14.53B 7.87B Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Pacira USD -1.93M 10.63M Jun/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Supernus Pharmaceuticals USD -57.95M 74.62M Sep/2025
United Therapeutics USD 438M 29.6M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025